Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  9, 1033 - 1038 (2003)
Published online: 20 July 2003; | doi:10.1038/nm904

BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect

Andrew R Hallahan1, 2, Joel I Pritchard1, Roshantha A S Chandraratna3, Richard G Ellenbogen4, J Russel Geyer2, Ryan P Overland1, Andrew D Strand1, Stephen J Tapscott5 & James M Olson1, 2

1  Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

2  Division of Pediatric Oncology, University of Washington/Children's Hospital, Seattle, Washington 98105, USA.

3  Retinoid Research, Allergan Incorporated, Irvine, California 92623, USA.

4  Department of Neurosurgery, University of Washington/Children's Hospital, Seattle, Washington 98105, USA.

5  Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

Correspondence should be addressed to James M Olson jolson@fhcrc.org
The mechanisms of retinoid activity in tumors remain largely unknown. Here we establish that retinoids cause extensive apoptosis of medulloblastoma cells. In a xenograft model, retinoids largely abrogated tumor growth. Using receptor-specific retinoid agonists, we defined a subset of mRNAs that were induced by all active retinoids in retinoid-sensitive cell lines. We also identified bone morphogenetic protein-2 (BMP-2) as a candidate mediator of retinoid activity. BMP-2 protein induced medulloblastoma cell apoptosis, whereas the BMP-2 antagonist noggin blocked both retinoid and BMP-2-induced apoptosis. BMP-2 also induced p38 mitogen-activated protein kinase (MAPK), which is necessary for BMP-2- and retinoid-induced apoptosis. Retinoid-resistant medulloblastoma cells underwent apoptosis when treated with BMP-2 or when cultured with retinoid-sensitive medulloblastoma cells. Retinoid-induced expression of BMP-2 is thus necessary and sufficient for apoptosis of retinoid-responsive cells, and expression of BMP-2 by retinoid-sensitive cells is sufficient to induce apoptosis in surrounding retinoid-resistant cells.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Signaling revisited in acute promyelocytic leukemia
Leukemia Reviews (01 Oct 2002)
Retinoic acid resistance in acute promyelocytic leukemia
Leukemia Reviews (01 Oct 2002)

RESEARCH
IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein
British Journal of Cancer Original Article (21 Jan 2002)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

naturejobs

Competing financial interests
Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy